Literature DB >> 19547874

Mutations in rpoB and katG genes in Mycobacterium isolates from the Southeast of Mexico.

R Zenteno-Cuevas1, J C Zenteno, A Cuellar, B Cuevas, C L Sampieri, J E Riviera, A Parissi.   

Abstract

The most frequent mutations associated with rifampin and isoniazid resistance in Mycobacterium are the substitutions at codons 531 and 315 in the rpoB and katG genes, respectively. Hence, the aim of this study was to characterize these mutations in Mycobacterium isolates from patients suspected to be infected with drug-resistant (DR) pulmonary tuberculosis (TB) in Veracruz, Mexico. Drug susceptibility testing of 25 clinical isolates revealed that five were susceptible while 20 (80%) were DR (15% of the annual prevalence for Veracruz). Of the DR isolates, 15 (75%) were resistant to rifampin, 17 (85%) to isoniazid and 15 (75%) were resistant to both drugs (MDR). Sequencing analysis performed in the isolates showed that 14 (93%) had mutations in the rpoB gene; seven of these (47%) exhibited a mutation at 531 (S-->L). Ten (58%) of the 20 resistant isolates showed mutations in katG; nine (52%) of these 10 exhibited a mutation at 315 (S-->T). In conclusion, the DR profile of the isolates suggests a significant number of different DR-TB strains with a low frequency of mutation at codons 531 and 315 in rpoB and katG, respectively. This result leads us to consider different regions of the same genes, as well as other genes for further analysis, which is important if a genetic-based diagnosis of DR-TB is to be developed for this region.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19547874     DOI: 10.1590/s0074-02762009000300012

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  6 in total

1.  Predictive value of molecular drug resistance testing of Mycobacterium tuberculosis isolates in Valle del Cauca, Colombia.

Authors:  Beatriz E Ferro; Pamela K García; Luisa Maria Nieto; Dick van Soolingen
Journal:  J Clin Microbiol       Date:  2013-05-08       Impact factor: 5.948

2.  Characterization of mutations in the rpoB gene conferring rifampicin resistance in Mycobacterium tuberculosis complex isolated from lymph nodes of slaughtered cattle from South Africa.

Authors:  Nolwazi L Bhembe; Ezekiel Green
Journal:  Braz J Microbiol       Date:  2020-08-05       Impact factor: 2.476

3.  Genotypic Detection of rpoB and katG Gene Mutations Associated with Rifampicin and Isoniazid Resistance in Mycobacterium Tuberculosis Isolates: A Local Scenario (Kelantan).

Authors:  Nurul-Ain Ismail; Mohd Fazli Ismail; Siti Suraiya Md Noor; Siti Nazrina Camalxaman
Journal:  Malays J Med Sci       Date:  2016-01

4.  Direct Whole-Genome Sequencing of Sputum Accurately Identifies Drug-Resistant Mycobacterium tuberculosis Faster than MGIT Culture Sequencing.

Authors:  Ronan M Doyle; Carrie Burgess; Rachel Williams; Rebecca Gorton; Helen Booth; James Brown; Josephine M Bryant; Jackie Chan; Dean Creer; Jolyon Holdstock; Heinke Kunst; Stefan Lozewicz; Gareth Platt; Erika Yara Romero; Graham Speight; Simon Tiberi; Ibrahim Abubakar; Marc Lipman; Timothy D McHugh; Judith Breuer
Journal:  J Clin Microbiol       Date:  2018-07-26       Impact factor: 5.948

5.  Whole genomic sequencing as a tool for diagnosis of drug and multidrug-resistance tuberculosis in an endemic region in Mexico.

Authors:  Carlos Francisco Madrazo-Moya; Irving Cancino-Muñoz; Betzaida Cuevas-Córdoba; Vanessa González-Covarrubias; Martín Barbosa-Amezcua; Xavier Soberón; Raquel Muñiz-Salazar; Armando Martínez-Guarneros; Claudia Bäcker; José Zarrabal-Meza; Clara Sampieri-Ramirez; Antonio Enciso-Moreno; Michael Lauzardo; Iñaki Comas; Roberto Zenteno-Cuevas
Journal:  PLoS One       Date:  2019-06-05       Impact factor: 3.240

6.  A systematic follow-up of Mycobacterium tuberculosis drug-resistance and associated genotypic lineages in the French Departments of the Americas over a seventeen-year period.

Authors:  Julie Millet; Elisabeth Streit; Mylène Berchel; Anne-Gaël Bomer; Franziska Schuster; Delaina Paasch; Jessica Vanhomwegen; Gilbert Cadelis; Nalin Rastogi
Journal:  Biomed Res Int       Date:  2014-03-13       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.